Birmingham, Ala., AUGUST 25, 2021 // Pack Health today announced that the company has undergone and passed a System and Organizational Controls (SOC) 2 Type II examination. The results demonstrate that Pack Health has maintained effective control over the security, availability, and confidentiality of its patient engagement platform and supporting systems.

This SOC 2 Type II report is designed to assure current and potential consumers of the effectiveness of controls related to security, availability, and processing integrity of the system used to process patient information. These results highlight Pack Health’s continued commitment to ensuring the security and privacy of patient health information. SOC 2 Type 2 certification logo

Pack Health has previously undergone a HITRUST Readiness Assessment prior to this SOC 2 Type II examination. “Industry-standard compliance initiatives have been a top priority for Pack Health. We manage highly sensitive patient data on our platform. Ensuring the protection of that data is paramount,” states Colin Durham, Pack Health’s Information Security Officer.

Pack Health’s patient engagement platform serves thousands of individuals; therefore, obtaining sensitive health-related information is necessary. With these ongoing security assessments, Pack Health aims to mitigate risks related to the security, availability, and confidentiality of patient information.

“Healthcare organizations are under pressure to comply with regulations which require the utmost care in handling patient data,” Durham continues. “Achieving this benchmark is a validation of our ongoing commitment to meet the data privacy needs of our members and partners.”

For more information, please visit


About Pack Health

Pack Health is an evidence-based patient engagement platform that changes health behaviors to close gaps in care and improve outcomes. The high-touch engagement model is proven to increase care access, improve patient centricity, and reduce costs. Pack Health comprehensively addresses chronic conditions, comorbidities, social determinants, and barriers to drive results across industries, including life sciences, health systems, health plans, and research.